Charlotte Andersson1, Asya Lyass2, Ramachandran S Vasan3, Joseph M Massaro4, Ralph B D'Agostino2, Sander J Robins1. 1. Framingham Heart Study, Framingham, MA; Boston University School of Medicine, Boston, MA. 2. Framingham Heart Study, Framingham, MA; Department of Mathematics and Statistics, Boston University, Boston, MA. 3. Framingham Heart Study, Framingham, MA; Section of Preventive Medicine and Cardiology, Boston University School of Medicine, Boston, MA. 4. Framingham Heart Study, Framingham, MA; Department of Biostatistics, Boston University School of Public Health, Boston, MA.
Abstract
BACKGROUND: Blood levels of high low-density lipoprotein cholesterol (LDL-C), high triglycerides (TG), and low high-density lipoprotein cholesterol (HDL-C) have been associated with increased risk of cardiovascular disease (CVD). The long-term comparative CVD risk associated with these 3 major lipid classes in various combinations is, however, unknown. METHODS: A total of 3,501 participants of the Framingham Offspring Study (mean age 51 ± 10 years, 56% women) without CVD at baseline were followed up for incident CVD between 1987 and 2011. Participants were grouped according to baseline lipid values into 8 distinct categories to compare the prognostic significance of values within an optimal range to Third Report of the National Cholesterol Educational Program-defined high LDL-C (> 130 mg/dL), high TG (> 150 mg/dL), and/or low HDL-C (< 40 mg/dL) in various combinations using multivariable-adjusted Cox regression models. RESULTS: On follow-up (median 20.2 years), 724 (21%) had new-onset CVD. Adjusted for confounders and compared with the group with optimal lipid values, hazards ratios and population-attributable risks (PARs) were as follows: isolated low HDL-C, 1.93 (95% CI 1.37-2.71), PAR = 3.1%; isolated high LDL-C, 1.28 (1.03-1.59), PAR 6.4%; isolated high TG, 1.35 (0.91-1.98), PAR = 1.1% (not significant); low HDL-C and high LDL-C, 1.82 (1.33-2.49), PAR = 3.9%; low HDL-C and high TG, 1.74 (1.28-2.37), PAR = 3.9%; high LDL-C and high TG, 1.52 (1.12-2.07), PAR = 6.4%; and high LDL-C, high TG and low HDL-C 2.28 (1.73-3.02), PAR = 7.5%. CONCLUSIONS: Aside from isolated hypertriglyceridemia, low levels of HDL-C, high levels of LDL-C, and high levels of TG in any combination were associated with increased risk of CVD.
BACKGROUND: Blood levels of high low-density lipoprotein cholesterol (LDL-C), high triglycerides (TG), and low high-density lipoprotein cholesterol (HDL-C) have been associated with increased risk of cardiovascular disease (CVD). The long-term comparative CVD risk associated with these 3 major lipid classes in various combinations is, however, unknown. METHODS: A total of 3,501 participants of the Framingham Offspring Study (mean age 51 ± 10 years, 56% women) without CVD at baseline were followed up for incident CVD between 1987 and 2011. Participants were grouped according to baseline lipid values into 8 distinct categories to compare the prognostic significance of values within an optimal range to Third Report of the National Cholesterol Educational Program-defined high LDL-C (> 130 mg/dL), high TG (> 150 mg/dL), and/or low HDL-C (< 40 mg/dL) in various combinations using multivariable-adjusted Cox regression models. RESULTS: On follow-up (median 20.2 years), 724 (21%) had new-onset CVD. Adjusted for confounders and compared with the group with optimal lipid values, hazards ratios and population-attributable risks (PARs) were as follows: isolated low HDL-C, 1.93 (95% CI 1.37-2.71), PAR = 3.1%; isolated high LDL-C, 1.28 (1.03-1.59), PAR 6.4%; isolated high TG, 1.35 (0.91-1.98), PAR = 1.1% (not significant); low HDL-C and high LDL-C, 1.82 (1.33-2.49), PAR = 3.9%; low HDL-C and high TG, 1.74 (1.28-2.37), PAR = 3.9%; high LDL-C and high TG, 1.52 (1.12-2.07), PAR = 6.4%; and high LDL-C, high TG and low HDL-C 2.28 (1.73-3.02), PAR = 7.5%. CONCLUSIONS: Aside from isolated hypertriglyceridemia, low levels of HDL-C, high levels of LDL-C, and high levels of TG in any combination were associated with increased risk of CVD.
Authors: María Lazo-Porras; Antonio Bernabe-Ortiz; Germán Málaga; Robert H Gilman; Ana Acuña-Villaorduña; Deborah Cardenas-Montero; Liam Smeeth; J Jaime Miranda Journal: Atherosclerosis Date: 2015-12-29 Impact factor: 5.162
Authors: Jennifer S Lee; Po-Yin Chang; Ying Zhang; Jorge R Kizer; Lyle G Best; Barbara V Howard Journal: Diabetes Care Date: 2017-01-25 Impact factor: 19.112